+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan



Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan



Cancer Detection and Prevention 31(1): 3-11



To investigate prospectively the association between colorectal cancer screening and subsequent risk of colorectal cancer death in a large-scale population-based cohort study (the JPHC study) with a 13-year follow-up period in Japan. We analyzed data from a population-based cohort of 42,150 (20,326 men and 21,824 women) subjects. Subjects who had undergone fecal occult blood test (FOBT) screening during the preceding 12 months were defined as the screened group. A total of 132 colorectal cancer deaths and 597 cases of newly diagnosed colorectal cancer were identified during the follow-up period. We observed a nearly 70% decrease in colorectal cancer mortality in screened versus unscreened subjects (RR=0.28, 95% CI=0.13-0.61). Screening participation was associated with a 30% reduced risk of death from all causes other than colorectal cancer (RR=0.70, 95% CI=0.61-0.79). However, the extent of mortality reduction was greater for colorectal cancer than other causes. A significant decrease in the incidence of advanced colorectal cancer was seen in screened subjects (RR=0.41, 95% CI=0.27-0.63), although the overall incidence rate did not differ significantly between the screened and unscreened groups. Although self-selection bias could not be fully controlled, these findings suggest that colorectal cancer screening may be associated with a reduction in mortality from colorectal cancer in the Japanese population.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 013234399

Download citation: RISBibTeXText

PMID: 17289293

DOI: 10.1016/j.cdp.2006.11.002


Related references

Extending Colorectal Cancer Screening to Persons Aged 40 to 49 Years With Immunochemical Fecal Occult Blood Test: A Prospective Cohort Study of 513,283 Individuals. Journal of Clinical Gastroenterology 50(9): 761-768, 2017

Risk stratification and detection of new colorectal neoplasms after colorectal cancer screening with faecal occult blood test: experiences from a Danish screening cohort. European Journal of Gastroenterology and Hepatology 27(12): 1433-1437, 2016

A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study. International Journal of Cancer 128(10): 2415-2424, 2011

T1088 Comparison of An Immunochemical Fecal Occult Blood Test Vs Colonoscopy for Colorectal Cancer Screening in the Familiar-Risk Population: A Prospective Randomized Study. Gastroenterology 134(4): A-480-A-481, 2008

Colorectal cancer screening with fecal occult blood test: A 22-year cohort study. Oncology Letters 6(2): 576-582, 2013

Prospective comparative evaluation of an office-based rapid immunological test with a Guaiac-based fecal occult blood test for colorectal cancer screening in general population with average-risk. Clinical Laboratory 54(9-10): 385-387, 2009

An evaluation of mass screening using fecal occult blood test for colorectal cancer in Japan: a case-control study. Japanese Journal of Cancer Research 84(11): 1110-1112, 1993

Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. Scandinavian Journal of Gastroenterology 24(5): 599-606, 1989

Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen in Denmark. Scandinavian Journal of Gastroenterology 22(6): 677-686, 1987

Barriers related to fecal occult blood test for colorectal cancer screening in moderate risk individuals. Journal of Education and Health Promotion 3: 120, 2014

Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer. European Journal of Gastroenterology and Hepatology 18(10): 1079-1083, 2006

The cumulative risk of false-positive fecal occult blood test after 10 years of colorectal cancer screening. Cancer Epidemiology, Biomarkers & Prevention 22(9): 1612-1619, 2014

Surveillance Colonoscopies in an Organized Colorectal Cancer Screening Program With Guaiac Fecal Occult Blood Test: A Population-Based Cohort Study. Gastroenterology 146(5): S-32, 2014

Screening test for colorectal cancer. Practical experiences with fecal testing for occult blood. 2: Rate of a false-negative occult blood test. Zeitschrift für Arztliche Fortbildung 81(20): 1057-1059, 1987

Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test: A case-control study. International Journal of Cancer 61(4): 465-469, 1995